HCW Biologics Inc.
0.35
0.01 (2.22%)
At close: Jan 15, 2025, 3:59 PM
0.36
3.37%
After-hours Jan 15, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -24.99M -14.90M -12.86M -5.80M -7.29M
Depreciation & Amortization 1.14M 717.85K 543.60K 595.91K 421.82K
Stock-Based Compensation 1.00M 1.12M 360.98K 21.88K 1.76K
Other Working Capital -5.14M 2.35M -2.80M -2.12M -662.22K
Other Non-Cash Items 4.98M 188.46K 28.26K 4.32M 79.00K
Deferred Income Tax n/a n/a -501.48K -4.32M -79.00K
Change in Working Capital -4.64M 2.49M 1.46M -5.25M 104.17K
Operating Cash Flow -22.51M -10.39M -10.98M -10.43M -6.77M
Capital Expenditures -6.20M -10.28M -47.26K -186.68K -1.46M
Acquisitions n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a -34.97M n/a n/a
Sales Maturities Of Investments 10.00M 24.98M n/a n/a n/a
Other Investing Acitivies n/a 24.98M -34.97M n/a 164.00
Investing Cash Flow 3.80M 14.71M -35.02M -186.68K -1.46M
Debt Repayment -38.27K 6.45M n/a 563.59K n/a
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a -2.82M n/a n/a
Other Financial Acitivies n/a -190.55K -6.76M 22.30M 26.83M
Financial Cash Flow -14.53K 6.27M 49.27M 11.72M 13.45M
Net Cash Flow -18.73M 10.60M 3.27M 1.10M 5.22M
Free Cash Flow -28.72M -20.66M -11.02M -10.62M -8.23M